Fridriksdottir Hafrun
SEC CIK 1561458 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Executive VP, Gbl R, D | 1,387 | — | $1.94M | 8 | 2021-08-10 | 2022-05-17 |
Most active insiders at TEVA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Francis Richard D | Pres, CEO | — | $31.26M |
| 2 | MIGNONE ROBERTO | Dir | — | $22.82M |
| 3 | Kalif Eliyahu Sharon | EVP, CFO | — | $20.72M |
| 4 | Sabag Mark | See "Remarks" | — | $13.15M |
| 5 | Daniell Richard | EVP, European Commercial | — | $12.08M |
| 6 | Hughes Eric A | See "Remarks" | — | $4.17M |
| 7 | Fox Christine | EVP, U.S. Commercial | — | $2.75M |
| 8 | Lippman Evan | EVP, Business Development | — | $2.16M |
| 9 | Weiss Amir | CAO | — | $1.41M |
| 10 | Shields Matthew | EVP, Gbl Ops | — | $1.40M |
Fridriksdottir Hafrun made no open-market trades at TEVA in the last 12 months.
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-19 | 2022-05-17 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Fridriksdottir Hafrun | Executive VP, Gbl R, D | S - Sale | $8.22 | -130.0K | 1,387 | -99% | -$1.07M | |
| DM | 2022-03-08 | 2022-03-04+ | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Fridriksdottir Hafrun | Executive VP, Gbl R, D | S - Sale+OE | $7.45 | -33.6K | 99.0K | -25% | -$250.2K |
| DM | 2022-03-08 | 2022-03-04+ | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Fridriksdottir Hafrun | Executive VP, Gbl R, D | M - OptEx | — | +94.2K | 117.0K | +412% | — |
| D | 2022-03-02 | 2022-02-28 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Fridriksdottir Hafrun | Executive VP, Gbl R, D | M - OptEx | — | +21.7K | 73.1K | +42% | — |
| D | 2022-03-02 | 2022-02-28 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Fridriksdottir Hafrun | Executive VP, Gbl R, D | S - Sale+OE | $8.14 | -7,590 | 65.5K | -10% | -$61.8K |
| D | 2022-02-10 | 2022-02-09 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Fridriksdottir Hafrun | Executive VP, Gbl R, D | M - OptEx | — | +16.1K | 57.5K | +39% | — |
| D | 2022-02-10 | 2022-02-09 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Fridriksdottir Hafrun | Executive VP, Gbl R, D | S - Sale+OE | $9.06 | -6,116 | 51.4K | -11% | -$55.4K |
| 2021-08-12 | 2021-08-10 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Fridriksdottir Hafrun | Executive VP, Gbl R, D | S - Sale | $9.95 | -50.9K | 41.4K | -55% | -$506.1K |
Purchase Sale Sale after option exercise All abbreviations